Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 44 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort studyOwen, C.; Ngian, G.; Elford, K.; Moore, O.; Stevens, W.; Nikpour, M.; Rabusa, C.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Sturgess, A.; Tymms, K.; Youssef, P.; Sahhar, J.
2014The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosisMorrisroe, K.; Stevens, W.; Nandurkar, H.; Prior, D.; Thakkar, V.; Roddy, J.; Zochling, J.; Sahhar, J.; Tymms, K.; Sturgess, A.; Major, G.; Kermeen, F.; Hill, C.; Walker, J.; Nash, P.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.
2012Novel biomarkers of dysregulated angiogenesis are not specific to pulmonary arterial hypertension in systemic sclerosisThakkar, V.; Patterson, K.; Stevens, W.; Byron, J.; Moore, O.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Youssef, P.; Proudman, S.; Nikpour, M.; Hissaria, P.; ARA-RHPA 53rd Annual Scientific Meeting (12 May 2012 - 15 May 2012 : Canberra, ACT)
2012Serum ICAM-1 levels are related to the presence of interstitial lung disease in systemic sclerosisThakkar, V.; Patterson, K.; Stevens, W.; Byron, J.; Moore, O.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Youssef, P.; Proudman, S.; Hissaria, P.; Nikpour, M.; ARA-RHPA 53rd Annual Scientific Meeting (12 May 2012 - 15 May 2012 : Canberra, ACT)
2013Assymetric dimethylarginine (ADMA) levels in the early detection of systemic sclerosis related pulmonary arterial hypertension (SSc-PAH)Thakkar, V.; Stevens, W.; Prior, D.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Youssef, P.; Proudman, S.; Nikpour, M.; Australian Rheumatology Association 54th Annual Scientific Meeting (18 May 2013 - 22 May 2013 : Perth, W.A.)
2014Mycophenolate mofetil versus azathioprine in scleroderma-associated interstitial lung disease: results from the Australian Scleroderma Cohort StudyOwen, C.; Ngian, G.; Elford, K.; Moore, O.; Nikpour, M.; Stevens, W.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Nash, P.; Sturgess, A.; Sahhar, J.; 2014 ACR/ARHP Annual Meeting (14 Nov 2014 - 19 Nov 2014 : Boston, MA)
2013Early accrual of organ damage in systemic sclerosis: rationale for forming a multinational inception cohort of patients with scleroderma (the INSYNC Study)Nikpour, M.; Stevens, W.; Roddy, J.; Zochling, J.; Sahhar, J.; Walker, J.; Thakkar, V.; Nash, P.; Youssef, P.; Tymms, K.; Schrieber, L.; Proudman, S.; Australian Rheumatology Association 54th Annual Scientific Meeting (18 May 2013 - 22 May 2013 : Perth, W.A.)
2014Cost savings with a biomarker-based screening algorithm for pulmonary arterial hypertension in systemic sclerosisQuinlivan, A.; Thakkar, V.; Stevens, W.; Prior, D.; Rabusa, C.; Youssef, P.; Gabbay, E.; Roddy, J.; Walker, J.; Zochling, J.; Sahhar, J.; Nash, P.; Lester, S.; Hill, C.; Rischmueller, M.; Proudman, S.; Nikpour, M.; 3rd Systemic Sclerosis World Congress (6 Feb 2014 - 8 Feb 2014 : Rome, Italy)
2014Associations between HLA DRB1 alleles and autoantibodies in systemic sclerosisLester, S.; Patterson, K.; Walker, J.; Charlesworth, J.; Stankovich, J.; Stevens, W.; Sahhar, J.; Nash, P.; Roddy, J.; Hill, C.; Nikpour, M.; Rischmueller, M.; Proudman, S.; Brown, M.; Zochling, J.; Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania)
2012Novel biomarkers of dysregulated angiogenesis are not specific to pulmonary arterial hypertension in SScThakkar, V.; Patterson, K.; Stevens, W.; Byron, J.; Moore, O.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Youssef, P.; Proudman, S.; Nikpour, M.; Hissaria, P.; 2nd Systemic Sclerosis World Congress (2 Feb 2012 - 4 Feb 2012 : Madrid, Spain)